{
    "id": "5c72aaed7c78d6947100006f",
    "question": "Is pazopanib an effective treatment of glioblastoma?",
    "options": {
        "A": "yes",
        "B": "no"
    },
    "answer": "B",
    "predict": "{\"step_by_step_thinking\": \"To determine if pazopanib is an effective treatment for glioblastoma, let's break down the available information and research findings.\\n\\nGlioblastoma is a type of brain cancer that is aggressive and difficult to treat. Pazopanib is a multi-targeted receptor tyrosine kinase inhibitor that has been investigated as a potential treatment for various cancers, including glioblastoma.\\n\\nResearch studies have shown that pazopanib can inhibit the growth of glioblastoma cells by targeting multiple pathways involved in tumor growth and angiogenesis. However, the efficacy of pazopanib in treating glioblastoma is still a topic of debate.\\n\\nA phase II clinical trial published in the Journal of Clinical Oncology found that pazopanib did not significantly improve overall survival or progression-free survival in patients with glioblastoma.\\n\\nAnother study published in the Journal of Neuro-Oncology found that pazopanib had some antitumor activity in glioblastoma, but the results were not sufficient to support its use as a standard treatment.\\n\\nConsidering these findings, it appears that pazopanib is not an effective treatment for glioblastoma, and its use is not widely recommended.\\n\\nTherefore, the answer is B. no.\", \"answer_choice\": \"B\"}",
    "snippets": [],
    "scores": [],
    "execution_time": 28.36901569366455
}